Literature DB >> 1903149

Cerebrovascular CO2 reactivity in migraine: assessment by transcranial Doppler ultrasound.

C Harer1, R von Kummer.   

Abstract

Cerebrovascular reactivity to CO2 inhalation was studied by transcranial Doppler sonography in 30 patients with classic or common migraine and 39 healthy controls without clinical or ultrasonic signs of arteriosclerosis. Systolic and diastolic Doppler frequencies of the middle cerebral artery were plotted against end-tidal CO2 partial pressure; the reactivity index (I x R) was defined as relative frequency change during a PCO2 increase of 5 mmHg. In the normal subjects, I x R was 20.0 +/- 6.3 for systolic velocities, and 26.0 +/- 8.2 for diastolic values. Migraineurs during their headache-free interval had significantly higher I x R values on the affected side (mean: 41.6 systolic, 61.2 diastolic), compared with either controls (P less than 0.01) or the contralateral side (mean: 28.3 systolic, 30.8 diastolic; P less than 0.01). During the headache attack, CO2 reactivity was significantly lower than normal only for systolic velocities (mean: 8.3; P less than 0.05). Increased CO2 reactivity is thought to be one phenomenon of migraine. Transcranial Doppler CO2 testing of cerebrovascular reactivity is a reliable method that may be of interest for the diagnostic evaluation and management of migraine patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903149     DOI: 10.1007/bf00319705

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

1.  Prolonged vasospasm in migraine detected by noninvasive transcranial Doppler ultrasound.

Authors:  A Thie; K Spitzer; L Lachenmayer; K Kunze
Journal:  Headache       Date:  1988-04       Impact factor: 5.887

2.  Dependency of blood flow velocity in the middle cerebral artery on end-tidal carbon dioxide partial pressure--a transcranial ultrasound Doppler study.

Authors:  T M Markwalder; P Grolimund; R W Seiler; F Roth; R Aaslid
Journal:  J Cereb Blood Flow Metab       Date:  1984-09       Impact factor: 6.200

3.  [Localisation of neurological symptoms in migraine accompagnée (author's transl)].

Authors:  R von Kummer; E M Schäfer
Journal:  Nervenarzt       Date:  1981-03       Impact factor: 1.214

Review 4.  Cerebral blood flow in migraine and cortical spreading depression.

Authors:  M Lauritzen
Journal:  Acta Neurol Scand Suppl       Date:  1987

5.  Transcranial Doppler CO2 test for the detection of hemodynamically critical carotid artery stenoses and occlusions.

Authors:  B Widder; K Paulat; J Hackspacher; E Mayr
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

6.  Local vascular response to change in carbon dioxide tension. Long term observation in the cat's brain by means of the hydrogen clearance technique.

Authors:  R von Kummer
Journal:  Stroke       Date:  1984 Jan-Feb       Impact factor: 7.914

7.  Transcranial Doppler measurement of middle cerebral artery blood flow velocity: a validation study.

Authors:  C C Bishop; S Powell; D Rutt; N L Browse
Journal:  Stroke       Date:  1986 Sep-Oct       Impact factor: 7.914

8.  Long-lasting reduction of cortical blood flow of the brain after spreading depression with preserved autoregulation and impaired CO2 response.

Authors:  M Lauritzen
Journal:  J Cereb Blood Flow Metab       Date:  1984-12       Impact factor: 6.200

9.  Regulation of regional cerebral blood flow during and between migraine attacks.

Authors:  M Lauritzen; T S Olsen; N A Lassen; O B Paulson
Journal:  Ann Neurol       Date:  1983-11       Impact factor: 10.422

10.  Noninvasive assessment of CO2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions.

Authors:  E B Ringelstein; C Sievers; S Ecker; P A Schneider; S M Otis
Journal:  Stroke       Date:  1988-08       Impact factor: 7.914

View more
  13 in total

1.  Transcranial doppler sonography diagnostic value for the cerebral flow velocity changes in the interictal phase of classic migraine.

Authors:  Behnaz Sedighi; Hossein Ali Ebrahimi; Shirin Jabbarpour; Kaveh Shafiee
Journal:  Caspian J Intern Med       Date:  2011

Review 2.  An update on the blood vessel in migraine.

Authors:  K C Brennan; Andrew Charles
Journal:  Curr Opin Neurol       Date:  2010-06       Impact factor: 5.710

3.  Migraine complicated by brachial plexopathy as displayed by MRI and MRA: aberrant subclavian artery and cervical ribs.

Authors:  E H Saxton; T Q Miller; J D Collins
Journal:  J Natl Med Assoc       Date:  1999-06       Impact factor: 1.798

4.  Patients with migraine with aura have increased flow mediated dilation.

Authors:  Fabrizio Vernieri; Leo Moro; Claudia Altamura; Paola Palazzo; Raffaele Antonelli Incalzi; Paolo Maria Rossini; Claudio Pedone
Journal:  BMC Neurol       Date:  2010-03-10       Impact factor: 2.474

5.  Profiling cerebrovascular function in migraine: A systematic review and meta-analysis.

Authors:  Jemima Sa Dzator; Peter Rc Howe; Rachel Hx Wong
Journal:  J Cereb Blood Flow Metab       Date:  2020-10-22       Impact factor: 6.200

Review 6.  Headache and facial pain in scuba divers.

Authors:  William P Cheshire
Journal:  Curr Pain Headache Rep       Date:  2004-08

7.  Multimodal tests of cerebrovascular reactivity in migraine: a transcranial Doppler study.

Authors:  A Thie; M Carvajal-Lizano; U Schlichting; K Spitzer; K Kunze
Journal:  J Neurol       Date:  1992-07       Impact factor: 4.849

Review 8.  The autonomic nervous system and the regulation of arterial tone in migraine.

Authors:  L L Thomsen; J Olesen
Journal:  Clin Auton Res       Date:  1995-10       Impact factor: 4.435

Review 9.  Is there a persistent dysfunction of neurovascular coupling in migraine?

Authors:  Andrej Fabjan; Marjan Zaletel; Bojana Žvan
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

10.  Cerebral Hemodynamic Changes During Migraine Attacks and After Triptan Treatments.

Authors:  Bilgin Öztürk; Ömer Karadaş
Journal:  Noro Psikiyatr Ars       Date:  2019-02-12       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.